Cardiogen
Also known as Ala-Glu-Asp-Arg, AEDR
A short bioregulator peptide discussed in cardiovascular-aging research traditions, usually represented by the tetrapeptide Ala-Glu-Asp-Arg.
Overview
Cardiogen is a short bioregulator peptide generally represented as Ala-Glu-Asp-Arg. It is discussed in cardiovascular and aging-focused peptide literature.
The Science
The proposed research frame is tissue-specific signaling rather than classic receptor pharmacology.
- Cardiac cell models - cellular stress, repair, and aging hypotheses.
- Vascular biology - cardiovascular tissue resilience claims.
- Bioregulator category - evidence often comes from regional literature and preclinical systems.
Evidence Snapshot
Cardiogen should be treated as a research peptide with limited high-quality human evidence. The scientific question is whether short bioregulator peptides have reproducible tissue-specific effects.
Related
More in Longevity
5-Amino-1MQ
Research compoundLongevity
Not a peptideSmall molecule
A small-molecule compound that researchers and self-experimenters study for its effects on metabolism, body composition, cellular energy, and healthy aging. Often discussed as a tool for understanding and potentially optimizing metabolic flexibility through NNMT inhibition.
B12
FDA-approvedLongevity
Not a peptideVitamin
An essential water-soluble vitamin required for red blood cell formation, nervous-system function, DNA synthesis, and one-carbon metabolism; it is not a peptide.
Crystagen
Research compoundLongevity
A bioregulator peptide product discussed in immune and aging research contexts, with claims centered on immune resilience and cellular regulation rather than a single validated indication.